Skip to main content
. Author manuscript; available in PMC: 2018 Oct 3.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 9;79(Pt B):503–514. doi: 10.1016/j.pnpbp.2017.08.009

Fig. 13.

Fig. 13

Levels of mRNAs for gap junction proteins GJC2 (A, B) and GJA1 (C.D) in the WM of that four diagnostic groups. Graphs on the right compare levels of the three mRNAs in controls subjects to the overall group of psychiatric subjects. Diagnostic group abbreviations as in Fig. 8.